Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis

AIDS Treatment with Novel Anti-HIV Compounds Improved by Nanotechnology

(2010) Xiaowei Ma et al.   AAPS Journal

Potent Angiogenesis Inhibition by the Particulate Form of Fullerene Derivatives

(2010) Huan Meng et al.   ACS Nano

Specific Hemosiderin Deposition in Spleen Induced by a Low Dose of Cisplatin: Altered Iron Metabolism and Its Implication as an Acute Hemosiderin Formation Model

(2010) Yingze Wang et al.   CURRENT DRUG METABOLISM

Biomedical Activities of Endohedral Metallofullerene Optimized for Nanopharmaceutics

(2010) Jie Meng et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

Cathepsin S Mediates Gastric Cancer Cell Migration and Invasion via a Putative Network of Metastasis-Associated Proteins

(2010) Yang Yixuan et al.   JOURNAL OF PROTEOME RESEARCH

Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis

(2010) X.-J. Liang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-α mediated cellular immunity

(2009) Ying Liu et al.   BIOMATERIALS

The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials

(2008) Jun-Jie Yin et al.   BIOMATERIALS

Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048)

(2008) S. Kitada et al.   BLOOD

Cysteine cathepsin proteases as pharmacological targets in cancer

(2007) Carmela Palermo et al.   TRENDS IN PHARMACOLOGICAL SCIENCES